Topic · page 6 of 6

Cardiometabolic & kidney

Diabetes, obesity, CKD and their cardiovascular or cardiorenal outcomes, SGLT2i/GLP-1 RA outside a primary HF population

Briefs 201–238 of 238 placed here, newest publication first

Briefs in Cardiometabolic & kidney

Newest publication first

JAMA Cardiol1 Feb 2024
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical Trials
Secondary analysis
Eur J Prev Cardiol19 Jan 2024
Obesity and cardiovascular health
Research article
Eur J Prev Cardiol3 Jan 2024
Consumption of foods and beverages rich in added sugar associated with incident metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study
Cohort study
Eur J Prev Cardiol19 Dec 2023
Life’s Essential 8 and heart failure among patients with chronic kidney disease: the Kailuan Cohort Study
Cohort study
Circulation14 Dec 2023
Current Status and Principles for the Treatment and Prevention of Diabetic Foot Ulcers in the Cardiovascular Patient Population: A Scientific Statement From the American Heart Association
Guideline or statement
Circulation12 Nov 2023
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
Research article
N Engl J Med11 Nov 2023
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Randomised controlled trial
J Am Coll Cardiol7 Nov 2023
Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c
Secondary analysis
JAMA Cardiol1 Nov 2023
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020
Cross-sectional study
JACC Cardiovasc Imaging18 Oct 2023
Prevalence and Prognostic Importance of Abnormal Positron Emission Tomography Among Asymptomatic Patients With Diabetes Mellitus
Cohort study
J Am Coll Cardiol17 Oct 2023
10-Year Cardiovascular Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus
Cohort study
Circulation9 Oct 2023
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
Guideline or statement
Circulation9 Oct 2023
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
Guideline or statement
Eur J Prev Cardiol5 Oct 2023
Clinical outcomes with the use of sodium-glucose cotransporter-2 inhibitors in patients with atrial fibrillation and type 2 diabetes mellitus: a multi-centre, real-world cohort study
Cohort study
JAMA Cardiol1 Oct 2023
Insulin Resistance and N-Terminal Pro-B-Type Natriuretic Peptide Among Healthy Adults
Cross-sectional study
J Am Coll Cardiol26 Sep 2023
Impaired Renal Function and Major Cardiovascular Events in Young Adults
Cohort study
Eur J Prev Cardiol11 Sep 2023
Denture use and risk for cardiometabolic disease: observational and Mendelian randomization analyses
Cohort study
Eur J Heart Fail10 Sep 2023
Association Between Epicardial Adipose Tissue and Cardiac Dysfunction in Subjects with Severe Obesity
Cross-sectional study
JAMA Cardiol1 Aug 2023
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone
Meta-analysis
Eur Heart J29 Jun 2023
Joint association of loneliness and traditional risk factor control and incident cardiovascular disease in diabetes patients
Cohort study
Eur J Prev Cardiol14 Jun 2023
Validation and comparison of cardiovascular risk prediction equations in Chinese patients with Type 2 diabetes
Cohort study
Eur J Prev Cardiol14 Jun 2023
Progression from different blood glucose states to cardiovascular diseases: a prospective study based on multi-state model
Cohort study
Eur Heart J2 Jun 2023
Red meat consumption, cardiovascular diseases, and diabetes: a systematic review and meta-analysis
Meta-analysis
Eur J Prev Cardiol22 May 2023
Body weight time in target range and cardiovascular outcomes in adults with overweight/obesity and type 2 diabetes
Secondary analysis
Eur J Prev Cardiol12 May 2023
Combining serum metabolomic profiles with traditional risk factors improves 10-year cardiovascular risk prediction in people with type 2 diabetes
Cohort study
Eur J Prev Cardiol26 Apr 2023
Higher risk of adverse cardiovascular outcomes in females with type 2 diabetes Mellitus: an Umbrella review of systematic reviews
Meta-analysis
JACC Cardiovasc Imaging12 Apr 2023
Myocardial Tissue-Level Characteristics of Adults With Metabolically Healthy Obesity
Cohort study
Eur J Prev Cardiol12 Apr 2023
Association of prolactin with all-cause and cardiovascular mortality among patients with type 2 diabetes: a real-world study
Cohort study
Eur J Prev Cardiol11 Apr 2023
Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004–2015 studies
Cohort study
Circulation26 Feb 2020
Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes
Secondary analysis
Circulation11 Nov 2019
Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study
Randomised controlled trial
Eur Heart J31 Aug 2019
Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME® trial
Secondary analysis
Eur Heart J24 Dec 2018
Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials
Secondary analysis
JACC CardioOncolDate not resolved
Association Between Clonal Hematopoiesis and Cardiometabolic Disease: A Systematic Review and Meta-Analysis
Meta-analysis
JACC AdvDate not resolved
Bariatric Surgery Improves Cardiac Remodeling and Function in Adults With Preserved Left Ventricular Ejection Fraction
Cohort study
JACC AdvDate not resolved
Cardiovascular and Cerebrovascular Outcomes Risk Reduction Associated With Semaglutide vs Tirzepatide: A Target Trial Emulation
Research article
JACC AdvDate not resolved
Maternal Mortality and Cardio-Kidney-Metabolic Risk Factors Across High-Income Countries
Research article
JACC AdvDate not resolved
Worsening Kidney Function and Cardiovascular Outcomes in Type 2 Diabetes and Atherosclerotic Disease
Randomised controlled trial

All 238 Briefs in ExploreShowing Briefs 201–238 of 238, newest first